Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3

INTRODUCTION: Tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist, provides clinically meaningful improvements in glycaemic control and body weight loss in people with type 2 diabetes. The early efficacy profile of tirzepatide after treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Viljoen, Adie, Pantalone, Kevin M., Galindo, Rodolfo J., Cui, Xuewei, Huh, Ruth, Hemmingway, Andrea, Fernández Landó, Laura, Patel, Hiren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126190/
https://www.ncbi.nlm.nih.gov/pubmed/37000390
http://dx.doi.org/10.1007/s13300-023-01398-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126190/
https://www.ncbi.nlm.nih.gov/pubmed/37000390
http://dx.doi.org/10.1007/s13300-023-01398-1

Ejemplares similares